Notably, in this study, the reduction observed in non-HDL cholesterol levels was partly explaining the protection from CVD disease supporting the possibility that ASGR1 could play an additional role in lipoprotein metabolism as well as in atherosclerosis. The gene discussed is ASGR1; the disease is atherosclerosis.